Avricore Health (AVCRF) Total Non-Current Liabilities (2010 - 2021)
Avricore Health (AVCRF) posted quarterly Total Non-Current Liabilities of $885281.6 for Q4 2020, up 79.12% year-over-year from $494237.4 in Q1 2020, and up 79.12% quarter-over-quarter from $494237.4 in Q4 2019.
Avricore Health (AVCRF) Total Non-Current Liabilities (2010 - 2021) Analysis & Trends
Avricore Health (AVCRF) has reported Total Non-Current Liabilities for 6 consecutive years, with $885281.6 the latest figure, recorded in Q4 2020.
- In Q4 2020, Total Non-Current Liabilities rose 79.12% year-over-year to $885281.6; the TTM figure through Dec 2020 stood at $885281.6 (up 79.12% YoY), while the FY2020 annual figure was $861535.3, up 75.2% from the prior year.
- Total Non-Current Liabilities advanced to $885281.6 in Q4 2020 per AVCRF's latest filing, from $494237.4 in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $885281.6 in Q4 2020 and bottomed at $237787.0 in Q4 2017.
- Historically, Total Non-Current Liabilities has averaged $424655.4 across 5 years, with a median of $267897.4 in 2016.
- Annual changes were most pronounced in 2017 — Total Non-Current Liabilities decreased 11.24% — and 2019, when it jumped 107.6%.
- Avricore Health's Total Non-Current Liabilities stood at $267897.4 in 2016, then retreated by 11.24% to $237787.0 in 2017, then gained by 0.12% to $238073.7 in 2018, then jumped by 107.6% to $494237.4 in 2019, then jumped by 79.12% to $885281.6 in 2020.
- Business Quant data shows AVCRF's Total Non-Current Liabilities at $885281.6 in Q4 2020, $494237.4 in Q4 2019, and $238073.7 in Q4 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 108.64 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 85.84 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 715.49 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 5.45 Bn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 22.94 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 542.10 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 6.36 Bn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 3.39 Bn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 9.19 Bn |
| 10 | Avricore Health | 3.04 Mn | 3.01 Mn | -6.20 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -12.84 Mn |
| Sep 30, 2021 | -10.93 Mn |
| Jun 30, 2021 | -11.17 Mn |
| Dec 31, 2020 | -4.09 Mn |
| Dec 31, 2019 | 494,237.38 |
| Dec 31, 2018 | 238,073.69 |
| Dec 31, 2017 | 237,787.01 |
| Dec 31, 2016 | 267,897.44 |
| Jun 30, 2010 | 231,586.53 |